Schizo Flashcards

(38 cards)

1
Q

Positive symptoms

A

Hallucinations, delusions, ideas of influence from external forces, disorganized speech/disconnected thoughts
-dopamine antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Negative symptoms

A

Flat affect (no emotion), alogia (inability to carry convo), anhedonia (no pleasure in anything), avolition (lack of drive/motivation)
-SGA/atypical agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

FGA APS

A

-chlorpromazine (low potency)
-fluphenazine (high potency)
-haloperidol (high potency)
-perphenazine (med potency)
-thioridazine (mod/high potency)
-thiothixene (mod/high potency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

FGA SE

A

EPS, QTc prolongation, prolactin elevation, photosensitivity, blue gray skin, orthostatic hypotension, altered thermoregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SGA APS

A

Aripiprazole, Asenapine, Brexpiprazole, Cariprazine, Clozapine, Iloperidone, Lurasidone, Lumateperone, Olanzapine, Paliperidone, Pimavanserin, Quetiapine, Risperidone, Ziprasidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SGA SE

A

Metabolic syndrome, QTc prolongation, blood dyscrasia/neutropenia’s, seizure threshold, anticholinergic effects, sedation, prolactin elevation, ophthalmic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Short acting injectables

A

Chlorpromazine, Haloperidol, Fluphenazine, Olanzapine, Ziprasidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Long acting injectables

A

Fluphenazine, Haloperidol, Aripiprazole, Olanzapine, Risperidone, Paliperidone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Aripiprazole clinical pearls

A

-May be activating and less sedating than other AEDs
-Insomnia, AKATHISIA, restlessness
-LAI
-Can cause IMPULSIVITY bc of dopamine agonism
-ODT contains phenylalanine (allergy)
-Can be used in peds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Asenapine clinical pearls

A

-little weight gain, least sedating and anticholinergic
-do not eat or drink 10 mins after taking SL tab
-High risk QTc, topical patch can cause skin irritation, anaphylaxis can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Asenapine CI

A

severe hepatic diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Brexpiprazole (Rexulti) clinical pearls

A

-Impulsivity
-Akathisia (dose related), long half life (91 hrs), fewer metabolic changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cariprazine clinical pearls

A

-Akathisia (dose related), long half life (2-4 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Paliperidone (Invega)

A

-EPS, Prolactin
-LAI
-Can be used in PEDs
-No PO overlap required
-Food inc bioavailability
-Tab can be in stool
-Acts like FGA
-Must be on Sustenna for 4 months before put on trinza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clozapine clinical pearls

A

-Blood dyscrasia, metabolic risk, REMs program
-For refractory illness (suicidality), QTc, seizures, myocarditis, constipation, hypersialorrhea, worst for metabolic conditions (cholesterol/BP meds can help)
-Seizure risk inc with dose so might need a AED (mood stabilizer)
-If interrupted >48 hours, need to restart at lowest dose
-REMs: first 6 months: weekly draws, next 6 months: biweekly draws, 1 year: draws every month
-Should avoid benzos (lorazepam)
-orthostasis
-sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Iloperidone clinical pearls

A

-most likely to cause orthostatic hypotension (slow titration), QTc, less sedating, need 50% dose reduction if given w/ CYP inhibitors
-Not recommended in severe hepatic impairment
-cardio AE

17
Q

Lurasidone (Latuda) clinical pearls

A

-avoid strong CYP3A4 inhibitors/inducers
-less sedation and orthostasis
-Renal/hepatic dosing needed
-Depression associated with BPD as mono therapy or adjunct to lithium or VPA
-Can be used in PEDs

18
Q

Lumateperone clinical pearls

A

-no significant changes in metabolic parameters, not associated with inc in EPS
-Not recommended in breastfeeding
-Monitor w/ MRI for signs of multifocal lucoencepalophy
-May impair fertility, & during 3rd trimester can have EPS withdrawal, feeding disorder may occur

19
Q

Olanzapine clinical pearls

A

-Metabolic risks, DRESS
-Post injection delirium/sedation syndrome, REMs for LAI (3 hr observation), monitor ANC
-Should avoid if on lorazepam
-Lybalvi: olanzapine + samidorphan: less weight gain, need to be off opioids for 7-14 days before initiating
-Can be used in PEDs

20
Q

Pimavanserin clinical pearls

A

-Avoid CYP3A4s or reduce dose
-No dopamine receptor activity
-Used for treatment in hallucinations & delusions with parkinson’s disease (dopamine deficiency)
-Not recommended for renal compromise < 30 ml/min

21
Q

Quetiapine (Seroquel) clinical pearls

A

-Sedation, metabolic issues
-Can be misused
-Often prescribed for sleep
-Can cause cataracts
-Weight gain
-Can be used in PEDs

22
Q

Risperidone clinical pearls

A

-EPS, prolactin elevation
-Can be used in PEDs
-LAI
-Refrigeration
-There is a SQ injection that can not be touched after injected and needs to be carefully injected and pumped 50 times
-Acts like FGA

23
Q

Ziprasidone

A

-Give with food
-DRESS
-Used for manic crisis
-CI: no use in those at risk for QTc
-Cardo AE

24
Q

Acute dystonias

A

jaw locked up, trouble speaking

25
High risk APS for Acute dystonias
High potency or high dose FGA, younger men
26
Treatment for Acute dystonias
Anticholinergics, IM benzos, dec or d/c dose
27
Pseudoparkinsonism
tremor, postural abnormalities, difficulty turning
28
High risk APS for Pseudoparkinsonism
High potency or high dose FGA, older females
29
Treatment for Pseudoparkinsonism
Anticholinergics, dec or d/c agent
30
Akathisia
restlessness, pacing, shuffling, compulsion to stay in motion, distress
31
High risk APS for Akathisia
High potency FGA, aripiprazole, risperidone
32
Treatment for Akathisia
Beta-blockers, dec or d/c agent (propranolol, nadolol, metoprolol
33
Tardive dyskinesia
limb twisting, rocking, tongue thrusting
34
High risk APS for Tardive dyskinesia
High potency or high dose FGA, older female, AA
35
Treatment for Tardive dyskinesia
Prevention, d/c agent, switch APS (clozapine), use Ingrezza
36
NMS
Rare but lethal high potency drugs cause but possible all APS Risk: dehydration, organic mental disorder treatment: d/c APS increasedWBC,CPK,LFT
37
Benazines (ingrezza)
CI: MAOis Interactions: CYP3A4 inducers/inhibitors May prolong QTc
38
Metabloc syndrome
need 3 criteria: obesity, abnormal lipid panels, high BP, high BG